http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5872737

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article
issn 1478-6362
1478-6354
issueIdentifier 2
pageRange R54-
publicationName Arthritis Research & Therapy
startingPage R54
bibliographicCitation Bosello S, De Santis M, Lama G, Spanò C, Angelucci C, Tolusso B, Sica G, Ferraccioli G. B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial. Arthritis Research & Therapy. 2010 Mar 25;12(2):r54. doi: 10.1186/ar2965.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8dabad3640bc958063bda9362c48083
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6884-4301
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daad0390f1f43694651844d2f54698c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2589530daf57a59d4717064af7d8613
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3196-1336
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8178b64145282ddd55e0f6ba25924c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81715f753274e323f35d42d1464f5fe7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad4e24991f1d98142fee1af9655aa435
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adbb42099548e113a2a56e43e1ed784a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9108-6609
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81396c70b6c2a551a5af38cb70349623
date 2010-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20338043
https://doi.org/10.1186/ar2965
https://pubmed.ncbi.nlm.nih.gov/PMC2888203
isPartOf https://portal.issn.org/resource/ISSN/1478-6354
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30289
https://portal.issn.org/resource/ISSN/1478-6362
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial
discusses http://id.nlm.nih.gov/mesh/M0024272
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0495929
http://id.nlm.nih.gov/mesh/M0492191
http://id.nlm.nih.gov/mesh/M0011157
http://id.nlm.nih.gov/mesh/M0028321
http://id.nlm.nih.gov/mesh/M0305108
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d180f13a3f81bf5e3d1904187dad811f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6e56e541fa09f5bff0045b6f9fd464ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9179
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ef3376902b05bdf1d4f2870c2035036b
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134409758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128107971
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128423931

Total number of triples: 56.